These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1591383)

  • 21. Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo.
    You Y; Pu P; Huang Q; Xia Z; Wang C; Wang G; Yu C; Yu JJ; Reed E; Li QQ
    Int J Oncol; 2006 May; 28(5):1225-32. PubMed ID: 16596239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diastereomeric process control in the synthesis of 2'-O-(2-methoxyethyl) oligoribonucleotide phosphorothioates as antisense drugs.
    Ravikumar VT; Cole DL
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1639-45. PubMed ID: 14565485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacokinetics of antisense oligonucleotides.
    Agrawal S; Temsamani J
    Methods Mol Med; 1996; 1():247-70. PubMed ID: 21359727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays.
    Southern EM; Milner N; Mir KU
    Ciba Found Symp; 1997; 209():38-44; discussion 44-6. PubMed ID: 9383567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated number of off-target candidate sites for antisense oligonucleotides in human mRNA sequences.
    Yoshida T; Naito Y; Sasaki K; Uchida E; Sato Y; Naito M; Kawanishi T; Obika S; Inoue T
    Genes Cells; 2018 Jun; 23(6):448-455. PubMed ID: 29667281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
    Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
    Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational selection and quantitative evaluation of antisense oligonucleotides.
    Jayaraman A; Walton SP; Yarmush ML; Roth CM
    Biochim Biophys Acta; 2001 Aug; 1520(2):105-14. PubMed ID: 11513951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical and clinical pharmacology of antisense oligonucleotides.
    Marcusson EG; Yacyshyn BR; Shanahan WR; Dean NM
    Mol Biotechnol; 1999 Aug; 12(1):1-11. PubMed ID: 10554769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of modified antisense oligonucleotides in Xenopus laevis embryos.
    Lennox KA; Sabel JL; Johnson MJ; Moreira BG; Fletcher CA; Rose SD; Behlke MA; Laikhter AL; Walder JA; Dagle JM
    Oligonucleotides; 2006; 16(1):26-42. PubMed ID: 16584293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense oligonucleotide inhibition of encephalomyocarditis virus RNA translation.
    Sankar S; Cheah KC; Porter AG
    Eur J Biochem; 1989 Sep; 184(1):39-45. PubMed ID: 2476310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense RNA directed to the human papillomavirus type 16 E7 mRNA from herpes simplex virus type 1 derived vectors is expressed in CaSki cells and downregulates E7 mRNA.
    Kari I; Syrjänen S; Johansson B; Peri P; He B; Roizman B; Hukkanen V
    Virol J; 2007 Jun; 4():47. PubMed ID: 17547759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense strategies in degenerative joint diseases: sense or nonsense?
    Huber LC; Distler O; Gay RE; Gay S
    Adv Drug Deliv Rev; 2006 May; 58(2):285-99. PubMed ID: 16574269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The design of antisense RNA.
    Sczakiel G
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):439-44. PubMed ID: 9303196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.
    Bennett CF; Condon TP; Grimm S; Chan H; Chiang MY
    J Immunol; 1994 Apr; 152(7):3530-40. PubMed ID: 7511650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
    Sommer W; Heilig M
    Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
    Nash KL; Alexander GJ; Lever AM
    J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
    Branch AD
    Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantages of antisense drugs for the treatment of oral diseases.
    Nedbal W; Teichmann B
    Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):183-91. PubMed ID: 12162701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.